Find Clinical Trial


Trial Status:
Gender:
Condition:

CLINICAL TRIALS

Previous Page        Next Page

This is a 12 week study to test two herbal supplements (Trigonella foenum-graecum Seed Extract and Coccinia Grandis Extract)for Normalizing Elevated (pre-diabetic) Blood Glucose and improving Insulin Sensitivity. It is being conducted in Brisbane…

CONDITION: Metabolic and Endocrine

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 70 yrs

Attention Deficit Hyperactivity Disorder (ADHD) is a common behavioural condition that affects thousands of children and families in Australia. ADHD is a complex disorder involving difficulties with hyperactivity, concentration and…

CONDITION: Other

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 6 – 17 yrs

A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial With a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg,…

CONDITION: Metabolic and Endocrine

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 10 – 18 yrs

A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial With a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg,…

CONDITION: Metabolic and Endocrine

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 10 – 18 yrs

A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of…

CONDITION: Metabolic and Endocrine

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – Max yrs

The use of NOX66 as a tumour cell-specific sensitiser of radiation therapy may provide greater response to targeted radiation therapy within the tumour cells, with the tumour specific nature of…

CONDITION: Cancer

TRIAL STATUS: Recruiting

GENDER: Males

AGE GROUP: 18 – Max yrs

Researchers at QBI are looking for participants diagnosed with treatment-resistant Obsessive-Compulsive Disorder (OCD). If you are you between 18 and 70 years of age and live within reasonable travelling distance…

CONDITION: Mental Health

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 70 yrs

ARE YOU SHY? Do you get anxious in front of others? Do you feel embarrassed if you have to give a speech or perform at a public function? Do you…

CONDITION: Mental Health

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 64 yrs

If you or someone you know has been diagnosed with cluster headaches, a clinical research study may be an option.   Wesley Medical Research are looking for people who are…

CONDITION: Neurological

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 70 yrs

Researchers are trialling an investigational medication for the potential treatment of Plaque Psoriasis. By participating in this study you will help to obtain important information about whether this investigational medication…

CONDITION: Skin

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 75 yrs

This pilot study is investigating the effects of L-theanine, the most abundant amino acid present in tea leaves, as an adjunctive therapy for Generalised Anxiety Disorder (GAD). The ‘TAGS’ study…

CONDITION: Mental Health

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 70 yrs

A 24-week, double blind placebo study investigating the effects of the amino acid ‘N-acetylcysteine’ (NAC) in Obsessive-Compulsive Disorder (OCD). This NHMRC funded study is currently enrolling participants at 3 trial…

CONDITION: Mental Health

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 70 yrs

ARE YOU: A pre-diabetic OR type 2 diabetic (diet-controlled or taking Metformin only) Aged between 18 and 70 years Someone with no significant weight change in the last 6 months…

CONDITION: Metabolic and Endocrine

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 70 yrs

This trial is designed to evaluate the safety, tolerability, and preliminary efficacy of intra-tumour injections of SD-101 in combination with intravenous Keytruda (pembrolizumab) in patients with metastatic melanoma. Patients can have progressed…

CONDITION: Cancer

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 70 yrs

Free trial of light therapy for hair loss Are you male? Have premature hair loss that is troubling you? Are you 18 to 60 years old? You are likely eligible…

CONDITION: Skin

TRIAL STATUS: Recruiting

GENDER: Males

AGE GROUP: 18 – 60 yrs

What is the trial? Sponsor is developing the product RYI-018 as a potential treatment for non-alcoholic fatty liver disease (NAFLD), which is a very common disorder and refers to a…

CONDITION:

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 65 yrs

Help us trial a medication which may help to protect people against severe reactions to peanuts. We’re looking for healthy people aged 18-65 with with a documented peanut allergy (of…

CONDITION: Other

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 65 yrs

Currently the known risk of a woman being diagnosed with cervical cancer by the age of 85 years is 1 in 160. The study we are conducting will be investigating a…

CONDITION: Other

TRIAL STATUS: Recruiting

GENDER: Females

AGE GROUP: 18 – 50 yrs

Australian researchers are trialing a potential new treatment for Asthma. They are looking for volunteers to take part in the Australian arm of a worldwide study. This study will be…

CONDITION: Respiratory

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 100 yrs

ANB019-001: This study is investigating the drug ANB019 to treat Plaque Psoriasis and other related conditions also associated with abnormal inflammatory responses. ANB019 is a monoclonal antibody (mAb) meaning that it…

CONDITION: Inflammatory and Immune System

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 – 45 yrs


Previous Page        Next Page